|
35
|
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
PAR-25-226 · National Institutes of Health · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2024-11-22 |
2026-11-19 |
14 |
|
15
|
RFI Alzheimer’s Research Program (AZRP) Public
HT9427RFI2027AZRP · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2026-10-27 |
2026-12-04 |
29 |
|
15
|
Traumatic Brain Injury and Psychological Health Research Program Public Request for Information
HT9427RFI2027TBIPHRP · DEFENSE HEALTH AGENCY (DHA) · DEFENSE HEALTH AGENCY · other
|
biomedical clinical
mental behavioral health
public health
|
— |
2026-10-27 |
2026-12-11 |
36 |
|
8
|
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
PAR-27-012 · National Institutes of Health · other
|
biomedical clinical
public health
mental behavioral health
|
— |
2026-03-18 |
2028-11-02 |
728 |